| 名稱(chēng) | EGFR H773_V774insAH/BaF3 |
| 型號(hào) | CBP73220 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | EGFR H773_V774insAH/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- STEAP1/2的細(xì)胞模型
- CSF3R細(xì)胞篩選模型
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- RET基因如何檢測(cè)？
- 從“腫瘤免疫療法”發(fā)展，看“單抗、CAR-T”任重而道遠(yuǎn)！
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機(jī)制
- Science：腫瘤非整倍體與癌癥免疫療法反應(yīng)下降相關(guān)聯(lián)
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73220EGFR H773_V774insAH/BaF3
- 詳細(xì)內(nèi)容
| CBP73220 | |
| I. Introduction | |
Cell Line Name： | EGFR H773_V774insAH/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Useful for the study of enzyme kinetics, screening inhibitors, and selectivity profiling. |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
EGFR H773_V774insAH results in the insertion of two amino acids within the drug-binding pocket in the protein kinase domain of the Egfr protein between amino acids 773 and 774 (UniProt.org, PMID: 23371856). H773_V774insAH has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other Egfr exon 20 insertion mutations (PMID: 24353160). | |
| III. Representative Data | |
1. WB of EGFR H773_V774insAH/BaF3
| |
會(huì)員_a.png)